Resultados da busca - Jiménez-Expósito, Maria Jesús
- Mostrando 1 - 4 resultados de 4
-
1
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Stu... por Teófilo, Eugénio, Rocha-Pereira, Nuno, Kuhlmann, Birger, Antela, Antonio, Knechten, Heribert, Santos, Jesús, Jiménez-Expósito, Maria Jesús
Publicado em 2016Texto -
2
Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients with HIV Type 1 Infection por Jansen, Klaus, Sönnerborg, Anders, Brockmeyer, Norbert, Thalme, Anders, Svedhem, Veronica, Dupke, Stephan, Eychenne, Jean-Luc, Nakonz, Tina, Jimenez-Exposito, Maria Jesus, Pugliese, Pascal
Publicado em 2013Texto -
3
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+) por Leroy, Vincent, Angus, Peter, Bronowicki, Jean‐Pierre, Dore, Gregory J., Hezode, Christophe, Pianko, Stephen, Pol, Stanislas, Stuart, Katherine, Tse, Edmund, McPhee, Fiona, Bhore, Rafia, Jimenez‐Exposito, Maria Jesus, Thompson, Alexander J.
Publicado em 2016Texto -
4
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world... por Welzel, Tania M, Petersen, Jörg, Herzer, Kerstin, Ferenci, Peter, Gschwantler, Michael, Wedemeyer, Heiner, Berg, Thomas, Spengler, Ulrich, Weiland, Ola, van der Valk, Marc, Rockstroh, Jürgen, Peck-Radosavljevic, Markus, Zhao, Yue, Jimenez-Exposito, Maria Jesus, Zeuzem, Stefan
Publicado em 2016Texto